Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Titel:
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Auteur:
Kindler, Hedy L Novello, Silvia Bearz, Alessandra Ceresoli, Giovanni L Aerts, Joachim G J V Spicer, James Taylor, Paul Nackaerts, Kristiaan Greystoke, Alastair Jennens, Ross Calabrò, Luana Burgers, Jacobus A Santoro, Armando Cedrés, Susana Serwatowski, Piotr Ponce, Santiago Van Meerbeeck, Jan P Nowak, Anna K Blumenschein Jr, George Siegel, Jonathan M Kasten, Linda Köchert, Karl Walter, Annette O Childs, Barrett H Elbi, Cem Hassan, Raffit Fennell, Dean A